PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
11-Aug-2025 Global Disposable Syringes Market Analysis: Key Trends, Challenges, and Future Opportunities Vantage Market Research
11-Aug-2025 Amphastar Announces FDA Approval for Iron Sucrose Injection, USP ACCESS Newswire
11-Aug-2025 Global Clinical Laboratory Services Market Analysis: Key Trends, Challenges, and Future Opportunities Market Reports
11-Aug-2025 Weight Loss Drugs Market: Trends, Growth, and Future Outlook VMR
11-Aug-2025 Telepsychiatry Market Insights, Trends, Opportunities & Regional Analysis 2025 Vantage Market Research
11-Aug-2025 Relief Therapeutics Advances Publication of 2025 Half-Year Report Relief Therapeutics Holding SA
11-Aug-2025 Nyxoah Announces Preliminary Results for the Second Quarter of 2025 Nyxoah SA.
11-Aug-2025 Newron notes the publication of new preclinical research suggesting evenamide ameliorates schizophrenia-related dysfunction Newron Pharmaceuticals S.p.A.
11-Aug-2025 Trump May Reclassify Marijuana - MMJ BioPharma To Escape The DEA's Seven Year Cannabis Trial Roadblock? ACCESS Newswire
11-Aug-2025 IRLAB's CFO Viktor Siewertz Leaves the Company for a New Leading Position ACCESS Newswire
11-Aug-2025 Relief Therapeutics Advances Publication of 2025 Half-Year Report ACCESS Newswire
10-Aug-2025 TERRY COLE FIX IT! DEA Blocks FDA Cannabis Trials While Contaminated Marijuana Floods State Markets ACCESS Newswire
09-Aug-2025 Unlock the Power of MK-677: Your Guide to Buying MK-677 Ibutamoren Online ACCESS Newswire
09-Aug-2025 Top 6 Best Joint Supplements for Dogs to Support Canine Joint Health and Pain Relief ACCESS Newswire
09-Aug-2025 Buy MK-677 ibutamoren Capsules - Increase GH levels with Capsules ACCESS Newswire
08-Aug-2025 Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea Nyxoah SA.
08-Aug-2025 BioNxt Solutions Announces Closing of Final Tranche of Oversubscribed Convertible Debenture Unit Private Placement ACCESS Newswire
08-Aug-2025 AIML Innovations Closes Quantum Sciences Ltd. Restructuring ACCESS Newswire
08-Aug-2025 CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025 ACCESS Newswire
08-Aug-2025 Escalating Tariffs and Global Drug-Pricing Mandates Reshape Q3 2025 Healthcare IT Investment Strategies ACCESS Newswire